Jinhai Medical Technology Limited (Jinhai MedTech) reported that 9.00 million ordinary shares were issued in May 2026 following the exercise of share options, lifting the company’s total issued share count to 5.30 billion shares as at 31 May 2026. No treasury shares were held during the period.

The new shares originated from the Share Option Scheme adopted on 29 December 2023. Outstanding options under this scheme fell to 445.96 million after the 9.00 million-share exercise, which brought in HKD 5.72 million in cash proceeds for the month.

Authorised share capital remained unchanged at 8.00 billion ordinary shares with a par value of HKD 0.0025 each, equivalent to HKD 20.00 million. There were no movements in warrants, convertible securities, or other share-issuing arrangements.

Management confirmed that the company continued to meet the Hong Kong Stock Exchange’s 25% minimum public-float requirement at month-end.